Biocompatibility, Cytotoxicity, and Antibacterial Evaluation of Novel Chitosan-Based 3D Bioprinted Bone Scaffolds: In Vitro Study
DOI:
https://doi.org/10.15517/n6y6a095Keywords:
Three-dimensional bioprinting; Tissue engineering; Bone regeneration; Collagen; Chitosan; Hydroxyapatite; Health.Abstract
The objective of the study was the biologic characterisation of novel three dimensional (3D) bioprinted osseous scaffolds developed for bone tissue engineering, using biocompatibility, cytotoxicity analysis and antibacterial assay. A composite bioink comprising polyethylene glycol (PEG), polyethylene glycol diacrylate (PEGDA), hydroxyapatite (HAP), collagen (COL), and chitosan (CH)was formulated and 3D bioprinted into osseous scaffolds using Cellink Bio X, extrusion-based 3D bioprinter. In vitro biologic characterisation included 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for biocompatibility using MG-63 osteoblast-like cells, cytotoxicity analysis using zebrafish model, with Group A (3D bioprinted scaffolds) and Group B (Phosphate buffer saline). Antibacterial assay was performed using disc diffusion method, with Group A1(low concentration of 3D bioprinted scaffolds), Group A2 (high concentration of 3D bioprinted scaffolds), Group B (dimethyl sulfoxide), and Group C (20 mg Erythromycin and 20 mg Penicillin) against Staphylococcus aureus (S. aureus, MTCC 740), Streptococcus mutans (S. mutans, MTCC 890), Enterococcus faecalis (E. faecalis, MTCC 439), and Klebsiella pneumoniae (K. pneumoniae, MTCC 109). Biologic characterisation revealed good biocompatibility of Group A (3D bioprinted scaffolds) comparable to Group B (untreated MG63), at all time points. No significant difference in embryo viability was observed for both Groups A and B, with good length, prominent trunk, tail, and organ development. Antibacterial assay revealed significant intergroup activity across all tested strains (p = 0.000), with comparable zone of inhibition of Group A2 with the control against S. aureus and S. mutans. The biologic characterization of the novel 3D bioprinted osseous scaffolds revealed good biocompatibility, limited cytotoxicity, and promising antibacterial properties. These findings underscore the potential of the developed constructs for application in bone tissue engineering for enhancing overall health. Future studies should focus on osteogenic differentiation, mineralization, and in vivo performance.
Downloads
References
Bishop E.S., Mostafa S., Pakvasa M., Luu H.H., Lee M.J., Wolf J.M., et al. 3-D bioprinting technologies in tissue engineering and regenerative medicine: Current and future trends. Genes Dis. 2017; 4 (4): 185-195. DOI: https://doi.org/10.1016/j.gendis.2017.10.002
Arumugam P., Kaarthikeyan G., Eswaramoorthy R. Three-Dimensional Bioprinting: The Ultimate Pinnacle of Tissue Engineering. Cureus. 2024; 16 (4): e58029. DOI: https://doi.org/10.7759/cureus.58029
Ramesh S., Harrysson O., Rao P., Tamayol A., Cormier D., Zhang Y., et al. Extrusion bioprinting: Recent progress, challenges, and future opportunities. Bioprinting. 2021; 21: e00116. DOI: https://doi.org/10.1016/j.bprint.2020.e00116
Chen X.B., Anvari-Yazdi F., Duan X., Zimmerling A., Gharraei R., Sharma N.K., et al. Biomaterials / bioinks and extrusion bioprinting. Bioact Mater. 2023; 28: 511-536. DOI: https://doi.org/10.1016/j.bioactmat.2023.06.006
Gungor-Ozkerim P.S., Inci I., Zhang Y.S., Khademhosseini A., Dokmeci M.R. Bioinks for 3D bioprinting: an overview. Biomater Sci. 2018; 6 (5): 915-946. DOI: https://doi.org/10.1039/C7BM00765E
Krishna D.V., Sankar M.R. Persuasive factors on the bioink printability and cell viability in the extrusion-based 3D bioprinting for tissue regeneration applications. Engineered Regeneration. 2023; 4: 396-410. DOI: https://doi.org/10.1016/j.engreg.2023.07.002
Reddy M.S.B., Ponnamma D., Choudhary R., Sadasivuni K.K. A Comparative Review of Natural and Synthetic Biopolymer Composite Scaffolds. Polymers (Basel). 2021; 13 (7): 1105. DOI: https://doi.org/10.3390/polym13071105
Zhang J., Wehrle E., Rubert M., Müller R. 3D Bioprinting of Human Tissues: Biofabrication, Bioinks, and Bioreactors. Int J Mol Sci. 2021; 22 (8): 3971. DOI: https://doi.org/10.3390/ijms22083971
Salehi S., Ghomi H., Hassanzadeh-Tabrizi S.A., Koupaei N., Khodaei M. The effect of polyethylene glycol on printability, physical and mechanical properties and osteogenic potential of 3D-printed poly (l-lactic acid)/polyethylene glycol scaffold for bone tissue engineering. Int J Biol Macromol. 2022; 221: 1325-1334. DOI: https://doi.org/10.1016/j.ijbiomac.2022.09.027
Yousefiasl S., Sharifi E., Salahinejad E., Makvandi P., Irani S. Bioactive 3D-printed chitosan-based scaffolds for personalized craniofacial bone tissue engineering. Engineered Regeneration. 2023; 4: 1-11. DOI: https://doi.org/10.1016/j.engreg.2022.09.005
Guo C., Wu J., Zeng Y., Li H. Construction of 3D bioprinting of HAP/collagen scaffold in gelation bath for bone tissue engineering. Regen Biomater. 2023; 10: rbad067. DOI: https://doi.org/10.1093/rb/rbad067
Kontakis M.G., Moulin M., Andersson B., Norein N., Samanta A., Stelzl C., et al. Trabecular-bone mimicking osteoconductive collagen scaffolds: an optimized 3D printing approach using freeform reversible embedding of suspended hydrogels. 3D Print Med. 2025; 11 (1): 11. DOI: https://doi.org/10.1186/s41205-025-00255-0
Salehi S., Ghomi H., Hassanzadeh-Tabrizi S.A., Koupaei N., Khodaei M. Antibacterial and osteogenic properties of chitosan-polyethylene glycol nanofibre-coated 3D printed scaffold with vancomycin and insulin-like growth factor-1 release for bone repair. Int J Biol Macromol. 2025; 298: 139883. DOI: https://doi.org/10.1016/j.ijbiomac.2025.139883
Atay H.Y. Antibacterial Activity of Chitosan-Based Systems. Functional Chitosan. 2020; 457-89. DOI: https://doi.org/10.1007/978-981-15-0263-7_15
Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials. 2010; 31 (17): 4639-56. DOI: https://doi.org/10.1016/j.biomaterials.2010.02.044
Ielo I., Calabrese G., De Luca G., Conoci S. Recent Advances in Hydroxyapatite-Based Biocomposites for Bone Tissue Regeneration in Orthopedics. Int J Mol Sci. 2022; 23 (17): 9721. DOI: https://doi.org/10.3390/ijms23179721
Sharon V.M., Malaiappan S. Biocompatibility and periodontal regenerative potential of hydroxyapatite nanoparticles from Portunus Sanguinolentus Shells: A crystallographic, morphological, and molecular gene expression analysis. J Dent. 2025; 157: 105762. DOI: https://doi.org/10.1016/j.jdent.2025.105762
Fidler A.L., Boudko S.P., Rokas A., Hudson B.G. The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution. J Cell Sci. 2018; 131 (7): jcs203950. DOI: https://doi.org/10.1242/jcs.203950
Selvaraj V., Sekaran S., Dhanasekaran A., Warrier S. Type 1 collagen: Synthesis, structure and key functions in bone mineralization. Differentiation. 2024; 136: 100757. DOI: https://doi.org/10.1016/j.diff.2024.100757
Seibel M.J. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005; 26 (4): 97-122.
Pramanik S., Aggarwal A., Kadi A., Alhomrani M., Alamri A.S., Alsanie W.F., et al. Chitosan alchemy: transforming tissue engineering and wound healing. RSC Adv. 2024; 14 (27): 19219-19256. DOI: https://doi.org/10.1039/D4RA01594K
Vaidya G., Pramanik S., Kadi A., Rayshan A.R., Abualsoud B.M., Ansari M.J., et al. Injecting hope: chitosan hydrogels as bone regeneration innovators. J Biomater Sci Polym Ed. 2024; 35 (5): 756-797. DOI: https://doi.org/10.1080/09205063.2024.2304952
Kim Y., Zharkinbekov Z., Raziyeva K., Tabyldiyeva L., Berikova K., Zhumagul D., et al. Chitosan-Based Biomaterials for Tissue Regeneration. Pharmaceutics. 2023; 15 (3): 807. DOI: https://doi.org/10.3390/pharmaceutics15030807
Kudiyarasu S., Karuppan Perumal M.K., Rajan Renuka R., Manickam Natrajan P. Chitosan composite with mesenchymal stem cells: Properties, mechanism, and its application in bone regeneration. Int J Biol Macromol. 2024; 275 (Pt 1): 133502. DOI: https://doi.org/10.1016/j.ijbiomac.2024.133502
Aguilar A., Zein N., Harmouch E., Hafdi B., Bornert F., Offner D., et al. Application of Chitosan in Bone and Dental Engineering. Molecules. 2019; 24 (16): 3009. DOI: https://doi.org/10.3390/molecules24163009
Oh Y., Ahn C.B., Marasinghe M.P.C.K., Je J.Y. Insertion of gallic acid onto chitosan promotes the differentiation of osteoblasts from murine bone marrow-derived mesenchymal stem cells. Int J Biol Macromol. 2021; 183: 1410-1418. DOI: https://doi.org/10.1016/j.ijbiomac.2021.05.122
Published
Issue
Section
License
Copyright (c) 2026 Parkavi Arumugam, Dhivya Sarathi, Kaarthikeyan Gurumoorthy, Ramanarayana Boyapati.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
ODOVTOS - Int. J. Dent. Sc. endorses CC BY-NC-SA
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms. CC BY-NC-SA includes the following elements:
BY: credit must be given to the creator.
NC: Only noncommercial uses of the work are permitted.
SA: Adaptations must be shared under the same terms.
